This study is completed in Belgium and in Finland. It is testing Safety and Pharmacokinetics of Single-and Multiple-Dose Extended-Release OROS Paliperidone for Schizophrenia.
This study exists to compare options and see whether the medication Five offers something meaningfully different. Researchers are trying to understand whether the medication Five can give earlier or clearer feedback during care.
In Belgium
Schizophrenia, Depression, ...DrugFrom 18 Years to 70 Years
This study exists to explore whether the medication CVL-231 could improve care and understanding. Researchers are trying to understand what the medication CVL-231 can reveal about signals in the brain or body that may guide care later on.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.